Journal
IMMUNITY
Volume 28, Issue 4, Pages 440-444Publisher
CELL PRESS
DOI: 10.1016/j.immuni.2008.03.005
Keywords
-
Categories
Ask authors/readers for more resources
Biological therapies targeting cytokines, T cells, or B cells have improved outcomes of inflammatory diseases. However, many issues remain open: What is the best target? How well can response be predicted? How can cure be achieved?.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
